B-type natriuretic peptide is associated with mortality in older functionally impaired patients

Journal of the American Geriatrics Society

Volumn 53, Issue 11, 2005, Pages 1991-1995

  Witham, Miles D ^a   Gillespie, Neil D ^a   Hutcheon, Stuart D ^b   Struthers, Allan D ^a   McMurdo, Marion E T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Aged; Natriuretic peptide; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELDERLY CARE; FEMALE; FUNCTIONAL DISEASE; GERIATRIC ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; RADIOIMMUNOASSAY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHRONIC DISEASE; COHORT STUDIES; DISABLED PERSONS; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; SCOTLAND; SURVIVAL ANALYSIS;

EID: 29244453229     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53555.x     Document Type: Article

References (22)

1. Maeda K, Tsutamoto T, Wada A et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832.
2. Cowie MR, Jourdain P, Maisel A et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-1718.
3. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167.
4. Deo R, Lemos JA. B-type natriuretic peptide in ischemic heart disease. Curr Cardiol Rep 2003;5:271-277.
5. Bassan R, Potsch A, Maisel A et al. B-type natriuretic peptide. A novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005;26:234-240.
6. Hutcheon SD, Gillespie ND, Struthers AD et al. B-type natriuretic peptide in the diagnosis of cardiac disease in elderly day hospital patients. Age Ageing 2002;31:295-301.
7. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004;93:1555-1558.
8. Weber M, Arnold R, Rau M et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004;94:740-745.
9. Wang TJ, Larson MG, Levy D et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-663.
10. Casiglia E, Spolaore P, Ginocchio G et al. Predictors of mortality in very old subjects aged 80 years or over. Eur J Epidemiol 1993;9:577-586.
11. Casiglia E, Mazza A, Tikhonoff V et al. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. J Hum Hypertens 2002;16:21-31.
12. Nybo H, Petersen HC, Gaist D et al. Predictors of mortality in 2,249 nonagenarians - the Danish 1905-Cohort Survey. J Am Geriatr Soc 2003;51:1365-1373.
13. Dontas AS, Toupadaki N, Tzonou A et al. Survival in the oldest old. Death risk factors in old and very old subjects. J Aging Health 1996;8:220-237.
14. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
15. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM et al. Total cholesterol and risk of mortality in the oldest old. Lancet 1997;350:1119-1123.
16. Kahn RL, Goldfarb AI, Pollack M et al. A. Brief objective measures for the determination of mental status in the aged. Am J Psychiatry 1960;117:326-328.
17. Emberson JR, Whincup PH, Lawlor DA et al. Coronary heart disease prevention in clinical practice. Are patients with diabetes special? Evidence from two studies of older men and women. Heart 2005;91:451-455.
18. Nolan L, O'Malley K. Prescribing for the elderly. Part I. Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988;36:142-149.
19. Wallen T, Landahl S, Hedner T et al. Atrial natriuretic peptides predict mortality in the elderly. J Intern Med 1997;241:269-275.
20. Wallen T, Landahl S, Hedner T et al. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997;77:264-267.
21. Sayama H, Nakamura Y, Saito N et al. Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects. Gerontology 2000;46:71-77.
22. Sington JD, Cottrell BJ. Analysis of the sensitivity of death certificates in 440 hospital deaths: A comparison with necropsy findings. J Clin Pathol 2002;55:499-502.